MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Compatible with caution

Aripiprazole 30mg tablets (Crescent Pharma Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (HBS Healthcare Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Key Pharmaceuticals Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Krka UK Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Macleods Pharma UK Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Medical Valley Invest AB)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Medihealth (Northern) Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Milpharm Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Sandoz Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Sigma Pharmaceuticals Plc)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 30mg tablets (Viatris UK Healthcare Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 30mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 5mg tablets (A A H Pharmaceuticals Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 5mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 5mg tablets (Accord-UK Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 5mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 5mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 5mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Compatible with caution

Aripiprazole 5mg tablets (Amarox Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 5mg tablets suppliers

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 5mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Compatible with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.